Skip to content

Drug interactions

Piroxicam + Siponimod

Severity: Minor

Piroxicam and Siponimod: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Piroxicam is metabolized by CYP2C9 and may compete with siponimod for this pathway, though it is not a notable CYP2C9 inhibitor. Any rise in siponimod exposure is likely small. Piroxicam is mainly a substrate rather than an inhibitor, so the legacy concern is largely theoretical.

What this interaction means in plain words

Piroxicam and Siponimod have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Piroxicam belongs to Musculoskeletal; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible competition for CYP2C9 metabolism; piroxicam is not an established CYP2C9 inhibitor.

What to do

No routine adjustment is needed; confirm the patient's CYP2C9 genotype is not *3/*3 as required by siponimod labeling. Monitor for siponimod adverse effects such as bradycardia and lymphopenia.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Piroxicam and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Piroxicam with Siponimod?

MediHelp rates the interaction as minor. Piroxicam and Siponimod have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Piroxicam is metabolized by CYP2C9 and may compete with siponimod for this pathway, though it is not a notable CYP2C9 inhibitor. Any rise in siponimod exposure is likely small. Piroxicam is mainly a substrate rather than an inhibitor, so the legacy concern is largely theoretical.

How serious is the interaction between Piroxicam and Siponimod?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed; confirm the patient's CYP2C9 genotype is not *3/*3 as required by siponimod labeling. Monitor for siponimod adverse effects such as bradycardia and lymphopenia.

What other medicines interact with Piroxicam?

MediHelp also lists interactions of Piroxicam with, for example, Ketorolac intranasal, Ketorolac, Aceclofenac. The full list is on the Piroxicam page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in